Pralidoxime Chloride Market to Reach USD 346.9 Million by 2035, Growing at a CAGR of 4.01%
The Pralidoxime Chloride Market is witnessing steady growth due to its critical role in the treatment of organophosphate and nerve agent poisoning, conditions that pose significant public health and defense concerns globally. Pralidoxime chloride (2-PAM) is a cholinesterase reactivator widely used alongside atropine to reverse neuromuscular paralysis caused by toxic exposure. Its importance in emergency medicine, military preparedness, … Read more